Evaluating ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy

This study is ongoing, but not recruiting participants.

Study NCT00083616 Information provided by Amgen

First Received: May 26, 2004 Last Updated: November 19, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2008
Estimated Primary Completion Date:	May 2007 (Final data collection date for primary outcome measure)